Neutrophils are cells of the innate immune system that first respond and arrive to the site of infection. Melatonin modulates acute inflammatory responses by interfering with leukocyte recruitment. It is known that melatonin modulates granulocyte migration though the endothelial layer thereby acting on the endothelial cell. Here we investigated whether melatonin could modulate granulocyte infiltration by acting directly on granulocytes. Granulocyte infiltration into the peritoneal cavity was investigated in mice kept at normal light/dark conditions and mice kept under constant lighting. To induce migration of neutrophils from the blood into the injury site via the endothelial layer, a bacterial product N-formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLP) was injected into the peritoneal cavity. We found that the number of infiltrated granulocytes during the dark time was lower than that during the light time. It did not depend on circadian time. Moreover, the expression of an adhesion molecule, CD18, on granulocytes, was also lower during the dark time as compared with the light time. We have found that melatonin inhibited fMLP-induced CD18 up-regulation. Importantly, melatonin also inhibited the integrin-mediated granulocyte adhesion to intercellular adhesion molecule-coated plates. This study additionally showed that melatonin receptors MT2 and MT3/quinone reductase 2 (QR2) are expressed on granulocytes. Interestingly, melatonin increases the expression of its MT3/QR2 receptor. The fMLP-mediated CD18 up-regulation was inhibited by melatonin via MT2 receptor and the integrin-mediated granulocyte adhesion was inhibited by melatonin via MT3/QR2 and MT2 receptors. In conclusion, we show that melatonin suppresses granulocyte migration via endothelium by acting directly on granulocytes.
Introduction
Neutrophils are key mediators of the innate immune system. They respond to multiple chemoattractants and migrate from the blood to inflamed tissues during host responses to bacterial infection or tissue injury. Activation of endothelial cells by cytokines and bacterial products leads to increased neutrophil adhesion to the endothelium and trans-endothelial migration (1) . Transmigration of neutrophils consists of multiple steps: capture, rolling, arrest, adhesion and migration across the endothelium (2) . Neutrophil capture and rolling are mediated by binding of selectins (P selectin/CD62P and E-selectin/CD62E on endothelial cells as well as l-selectin /CD62L on leukocytes) to their ligands (2) . Chemokine receptor-mediated signaling triggers activation of leukocytes and expression of β2 integrins. β2 integrins (CD11/CD18) are heterodimeric glycoproteins that consist of a distinct α subunit (CD11a, b or c) and a common β subunit (CD18). Lymphocyte function-associated antigen-1 (LFA-1; CD11a/ CD18) and macrophage antigen-1 (Mac-1; CD11b/CD18) are very important for leukocyte adhesion functions (2) . Activated LFA-1 and Mac-1 integrins subsequently interact with their endothelium-expressed ligand intercellular adhesion molecule 1 (ICAM-1), which leads to a reduction of leukocyte rolling velocity or slow rolling and eventually to firm leukocyte arrest on the endothelium. Following firm adhesion, neutrophils prepare for extravasation into tissues and transmigration across the endothelial cell barrier (1, 2) . Mac-1 and ICAM-1 allow cells to crawl over the endothelium in order to search for the optimal spot for transmigration. LFA-1 and ICAM-1 mediate an initial neutrophil arrest and are important during rolling and adhesion (2) Melatonin is a hormone mainly produced by the pineal gland. It regulates the circadian day-night rhythm and seasonal bio-rhythms. It also modulates immune defence responses, body weight and reproduction and has tumor growth-inhibitory and anti-jet lag effects (3) . The production of melatonin occurs during the night in response to the darkness and is inhibited by the light (4) . Melatonin can bind three types of receptors: membrane receptors MT1 and MT2, cytosolic receptor MT3/quinone reductase 2 (QR2) and nuclear RORα, RORβ, RORγ receptors (5) .
MT3/QR2 is a cytosolic enzyme (5) . The physiological and pathological nature of MT3/QR2 is still also unclear. It is known that QR2 has a powerful capacity to activate quinones leading to production of free radicals [reactive oxygen species (ROS)] (6, 7). The production of free radicals could be inhibited by high concentrations of melatonin (8, 9) . On another site, it was also hypothesized that melatonin itself might serve as a substrate or a co-substrate of QR2 and participates in the production of ROS (10) . However, later studies by Boutin et al. demonstrated that melatonin is not a substrate or a cosubstrate of QR2 (11) .
Melatonin, acting via MT3/QR2, has been shown to inhibit the adhesion of rat leukocytes to the vascular endothelium (12, 13) . However, there are no data about the possible direct role/effect of melatonin on granulocytes.
Therefore, the aim of this study was to investigate the effect of melatonin on the integrin-mediated adhesion of granulocytes.
Methods

Experimental animals
BALB/c mice were bred and housed in our animal facility in accordance with the institutional guidelines for Ethical Conduct in the Care and Use of Animals. The rodents were given ad libitum access to food and water and maintained under a 12/12-h light/dark cycle. The lighting conditions were changed 1 week before the experiment. A group of animals was kept further under the same light/dark cycle (LD). Another group of mice (LL) was kept under constant artificial lighting (around 50 lux). The experiments were performed with 8-9-week-old mice.
N-formyl-l-methionyl-l-leucyl-l-phenylalanine (fMLP) (Sigma-Aldrich, St Louis, MO, USA) was used to induce the migration of granulocytes from blood to the peritoneal cavity. 1 ml of 1 µM fMLP solution in PBS was injected into the peritoneal cavity. The animals were sacrificed by cervical dislocation 4 h after fMLP injection. The mice were sacrificed around the midnight or around the midday.
Flow cytometry and antibodies
The expression of cell surface markers was analyzed by four-color flow cytometer (FACScalibur, Becton Dickinson). The peritoneal cavity and blood cells were stained with antiGr1-FITC (Miltenyi Biotec, Bergisch Gladbach, Germany), CD18-phycoerythrin (PE) (BD Biosciences, San Jose, CA, USA) and Mac-1-APC (Miltenyi Biotec). Granulocytes were identified as Mac-1 + Gr1 + .
Cell preparation
Purification of granulocytes from the peritoneal cavity for real-time PCR. The granulocytes were purified using negative selection with anti-R-PE magnetic particles -DM (BD Biosciences). Peritoneal cavity cells were stained with PE-labeled antibodies to mouse B220, CD5, CD4 and CD8 (BD Biosciences). The cell isolation was performed according the manufacturer's recommendations. Cell purity was estimated by flow cytometry and was 95-98%.
Isolation of leukocytes from the blood. The erythrocytes were lysed using lysing buffer (168 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM tetrasodium EDTA, pH to 7.3). One microliter of blood was diluted with 14 ml of lysing buffer and incubated at room temperature for 3-5 min. The cells were centrifuged at 300 × g for 5 min at 4°C, and the pellet was resuspended in cold PBS buffer. The cells were centrifuged again and resuspended in the medium required for future analysis.
The analysis of expression of CD18 on granulocytes in vitro
Isolated blood cells were resuspended in RPMI medium with 0.25% BSA and, 10 mM HEPES at a concentration of 5 × 10 6 cells/ml and incubated for 20 min with melatonin (SigmaAldrich); MT3/QR2 agonist, GR135531 (Tocris Bioscience, Bristol, UK) or MT2 agonist, IIK7 (Sigma-Aldrich). fMLP was added at a final concentration of 10 μM and the cells were incubated for 4 min at 37°C with 5% CO 2 . Stimulation was stopped by adding ice-cold FACS buffer (PBS with 2% FCS and 0.1% sodium azide). The cells were stained with antibodies anti-Gr1-FITC, CD18-PE and Mac-1-APC. Expression of CD18 on granulocytes (Mac-1 + Gr1 + ) was analyzed using FACScalibur and CellQuest software.
Granulocyte adhesion to plate-bound ICAM-1Fc
Nunc Maxisorp ELISA plates were coated with rmICAM-1Fc (R&D Systems, Minneapolis, MN, USA). rmICAM-1Fc was diluted in PBS at a concentration of 4 µg/ml and distributed 50 µl per well. The plates were coated overnight, blocked for 1 h with 150 µl of 1% BSA in PBS and washed three times with RPMI medium without serum. The blood cells were resuspended in RMPI medium with 0.25% BSA and 10 mM HEPES at a concentration of 5 × 10 6 cells/ml and treated for 20 min with MT3/QR2 antogonist, prazosin hydrochloride; MT3/QR2 agonist, GR135531 (Tocris Bioscience); MT2 antogonist, 4P-PDOT (Tocris Bioscience); RORα agonist, CGP52608 (Sigma-Aldrich); MT1/MT2 antogonist, luzindole (SigmaAldrich); RORγ inverse agonist, SR1555 (Sigma-Aldrich); MT2 agonist, IIK7 (Sigma-Aldrich); and melatonin (SigmaAldrich). When receptor antagonists and melatonin were used together, the cells were pre-incubated for 20 min with antagonist and then the melatonin was added.
When the adhesion was performed with unstimulated cells, the cells were transferred to the rmICAM-1Fc-coated wells (100 µl/well) and incubated for 30-40 min at 37°C with 5% CO 2 . The cells that had not adhered were washed out, and the plates gently washed 4-5 times with RPMI medium.
When the adhesion was performed with fMLP-stimulated cells, the cells were mixed with 10 μM of fMLP and immediately transferred to the rmICAM-1Fc-coated wells. After a short (4 min) incubation at 37°C with 5% CO 2 , the plate was placed on the ice, and unbound cells were removed by washing with ice-cold RMPI medium.
The antibody master mix for cell staining was prepared in staining medium (RPMI with 5 mM EDTA and 0.1% Na azide).
Fifty microliters of ice-cold master mix was added to each well and incubated for 30 min. The cells were released by pipetting. An additional 150 µl of ice-cold staining medium was added to every well, mixed and all medium with detached cells was transferred to the tubes for analysis. The cells were analyzed by flow cytometry. The adhesion % was calculated according the formula: adhesion % = (number of adherent cells)/(number of added cells to the well) × 100%. The experiments were performed during the light time.
Polymerase chain reaction
RNA isolation, cDNA synthesis and PCR were performed as described previously (14, 15) . Briefly: RNA was extracted using the GeneJET™ RNA Purification Kit (Thermo Fisher Scientific, Vilnius, Lithuania). PCR was performed in a real-time PCR cycler Rotor-Gene RG 6000-time PCR instrument. Primer sequences (Integrated DNA Technologies) and their annealing temperatures are listed in Table 1 . All primers (except MT1(C) and RORα) were designed using a Lasergene software (DNASTAR, Madison, WI, USA). The sequences of MT1(C) and RORα primers were as described in Carrillo-Vico et al. (16) . The primers for the nuclear receptors could be used to amplify all isoforms. According to the literature (5), all melatonin receptors are expressed in the brain. Therefore, brain cDNA served as a calibrator. The ubiquitously expressed hypoxanthine-guanine phosphoribosyltransferase (HPRT) mRNA was used to monitor the quality of RNA and the efficiency of the reverse transcription and the PCR processes. The relative quantities of each target gene were normalized to HPRT as a reference gene and were carried out according to the ABI PRISM 7700 Sequence Detection System bulletin #2 (17) . Additionally, calculation of the relative mRNA concentrations of target genes was carried out according to the 2 -∆∆cT method of Livak and Schmittgen (18) . The results obtained according to relative calibration curve and 2 -∆∆cT methods were similar. Additionally, PCR products were separated by electrophoresis in 2% agarose gels and visualized using a UV illuminator in the presence of ethidium bromide.
Results
The migration of granulocytes into peritoneum depends on lighting conditions
fMLP-induced granulocyte migration into the peritoneal cavity was investigated in mice kept at different lighting conditions. One group of BALB/c mice was kept at normal (12 h dark and 12 h light) lighting conditions (LD). The second mouse group was exposed to constant light (LL). The mice were injected intraperitoneally with fMLP and the numbers of granulocytes in the peritoneal cavity were measured 4 h post-injection. The counts of granulocytes in the peritoneum of the LL mice were significantly higher than those in the LD mice (Fig. 1A) when the cells were counted during the night. However, the numbers of granulocytes did not differ when the cells were counted during the day.
To explore if the differences in the granulocyte numbers are due to lighting conditions or circadian time, we compared granulocyte numbers in the same experiment from three mouse groups (Fig. 1B) . The intraperitoneal granulocytes were counted in the LD mice during the day and during the night and in the LL mice during the night. As in the previous experiment, during the night, we found more granulocytes in the peritoneum of the LL mice compared with the LD mice, but the LD mice had more granulocytes during the day, than during the night.
These data show that an increased melatonin concentration during the night could reduce granulocyte migration from the blood into the peritoneal cavity. To determinate whether this presumption is correct, we injected melatonin intravenously (1 h before fMLP injection) to the LD mice during the day. Fig. 1C shows the amount of granulocytes in the peritoneal cavity of melatonin-injected and control mice. Indeed, an increased melatonin concentration in the blood significantly reduced fMLP and induced granulocyte migration into the peritoneal cavity.
Taken together, fMLP-induced migration of granulocytes into the peritoneum depends on lighting conditions and the melatonin concentration in the blood. The primers according to Carrillo-Vico et al. (16) .
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The expression of CD18 on granulocytes depends on lighting conditions
Next, we wanted to know which receptor may be involved in the decreased granulocyte migration during the dark time.
We tested the expression of CD18, a receptor that is important for adhesion of granulocytes to endothelial cells (Fig. 2) . Significantly higher expression of CD18 on blood granulocytes was found during the light time (LD and LL mice during the day and also LL mice during the night) as compared with the dark time (LD mice during the night) ( Fig. 2A) . Similar expression of CD18 was obtained also on peritoneal granulocytes (Fig. 2B) . Again, the LD mice during the night had lower expression of CD18 as compared with the LD or LL mice during the day. Thus, the expression of CD18 on granulocytes is decreased during the dark time.
To determine whether melatonin could regulate CD18 expression, we stimulated blood cells in vitro with fMLP in the presence or absence of melatonin (Fig. 3) . The CD18 was upregulated on granulocytes after short (4 min) stimulation with fMLP. But, the expression of CD18 is significantly decreased if the cells were pre-incubated with melatonin. Moreover, the fMLP-induced CD18 expression is reduced after pre-incubation of the cells with MT2 agonist IIK7. The pre-incubation with MT3 agonist GR13531 did not influence fMLP-induced upregulation of CD18 granulocytes. Therefore, we could conclude that melatonin inhibits fMLP-induced up-regulation of CD18 on granulocytes via MT2 receptor.
Melatonin inhibits granulocyte adhesion to ICAM via MT3/ QR2 and MT2 receptors
We checked whether melatonin could influence granulocyte adhesion to ICAM. The granulocyte adhesion was investigated in vitro using rmICAM-1Fc-coated plates. The granulocytes were isolated from the blood of the LD mice during the light time, when the expression of CD18 and the granulocyte migration is higher. The adhesion was performed with unstimulated and fMLP cells. The adhesion of fMLP-stimulated granulocytes was observed after 3 min (Fig. 4) , while the unstimulated cells required 45 min for adherence. Melatonin significantly reduced both fMLP-stimulated (3 min adhesion) and unstimulated (45 min adhesion) granulocyte adhesion to the ICAM-coated plate.
Next, we wanted to know what melatonin receptors are involved in the reduced granulocyte adhesion. We checked what melatonin receptors are expressed in the granulocytes isolated during the dark time from the LD and LL mice, which displayed lower or higher granulocyte migration and CD18 expression, respectively. The granulocytes from LD and LL mice expressed MT3/QR2, RORγ and RORα receptors (Fig. 5A) . However, the surface receptors MT1 and MT2 were expressed only in granulocytes from LL mice. RORβ was not detectable.
In order to explore if melatonin could regulate the expression of its own receptors, 5 mg/kg of melatonin was injected into the peritoneum of LD and LL mice and 3 h post-injection, the mice were sacrificed. The granulocytes were isolated from the peritoneal cavity and the expression of melatonin receptors was analyzed by real-time PCR. The expression of MT3/QR2 and RORβ was up-regulated after treatment with melatonin in both groups of mice, whereas MT1 was up-regulated only in the LD mice (Fig. 5) . In conclusion, all melatonin receptors are expressed on granulocytes.
Next, we performed an adhesion assay in the presence of agonists and antagonists of different melatonin receptors.
Fig. 2. The expression of CD18 on granulocytes in the blood (A) and peritoneal cavity (B)
. The mice were kept at constant lighting (LL) or 12/12 light/ dark (LD) conditions 1 week before the experiment. The expression of CD18 was analyzed by flow cytometry around the midday (day) or around the midnight (night). fMLP was injected into the peritoneum to induce the migration of granulocytes, and the cells from the peritoneal cavity were isolated 4 h later. One circle means the mean fluorescence intensity (MFI) of CD18-PE of granulocytes from one mouse. Significant differences between two mice groups were calculated by Mann-Whitney U-test (**P ≤ 0.005; ***P ≤ 0.0005). One representative experiment (out of two) is shown. ) is shown as mean fluorescence intensity (MFI). Significant differences were calculated by the unpaired t-test (*P ≤ 0.05; **P ≤ 0.005). One representative experiment from two independent experiments is shown. Melatonin inhibits granulocyte adhesion to ICAM. The mice were kept at 12/12 light/dark conditions. The granulocytes from the blood were isolated during the day. The same samples were preincubated with 10 pM melatonin (mel) for 20 min. The granulocyte adhesion to the plates coated with rmICAM-1Fc was performed for 3 or 45 min in the presence or absence of fMLP(10 μM). Significant differences between the adhesion of melatonin treated and untreated cells were calculated by the unpaired t-test (*P ≤ 0.05). Fig. 6 shows how the adhesion of unstimulated granulocytes is affected by agonists and antagonists of melatonin receptors. Agonist of MT3/QR2, Gr135531, acted similarly to melatonin. It also significantly decreased the granulocyte adhesion to rmICAM-1Fc (Fig. 6A) . The combination of melatonin and Gr135531 did not show any synergistic effect. MT3/QR2 antagonist, prazosin hydrocholoride, alone did not influence the adhesion; however, it blocked the effect of melatonin. MT1/MT2 antagonist luzindole, MT2 antagonist 4P-PODT (Fig 6B) , RORα agonist CGP52608 and RORγ inverse agonist SE1555 (Fig. 6C) did not affect the adhesion, neither alone, nor when combination with melatonin. These data suggest that melatonin reduces unstimulated granulocyte adhesion to ICAM acting via the MT3/QR2 receptor. The other receptors (MT1, MT2, RORα or RORγ) are not involved. Fig. 7 shows how the adhesion of fMLP-stimulated granulocytes is affected by agonists and antagonists of melatonin receptors. Both, MT3/QR2 agonist GR135531 and melatonin suppressed fMLP-induced granulocytes adhesion (Fig.7A) . However, MT3 antagonist prazosin hydrochloride did not influence fMLP-induced granulocyte adhesion (Fig.7B) . MT2 agonist IIK7 also showed a similar effect to melatonin (Fig.7C) . MT2 receptor antagonist 4P-PDOT and MT1/MT2 antagonist luzindole restored the melatonin-suppressed adhesion ( Fig.7C and D) . Those data show that MT3/QR2 and MT2 receptors could be involved in a property of melatonin to regulate the fMLP-induced adhesion of granulocytes to ICAM.
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Discussion
Activation of neutrophils and their migration into the site of inflammation is important for a successful host defence. Circulating neutrophils can be activated by various stimuli, including fMLP. Activated neutrophils adhere to and spread over endothelial cells and extracellular matrix in a β2-integrindependent manner (19) and transmigrate into inflammation or injury sites.
Our results show that the fMLP-induced murine granulocyte migration is decreased during the dark time. We suggest that the hormone melatonin, produced by the pineal gland during the night, may contribute to attenuation of fMLP-induced intraperitoneal granulocyte accumulation. Many previous studies showed that melatonin regulates neutrophil migration. It inhibits neutrophil infiltration into rat liver, lungs and small intestine after injury (20) (21) (22) (23) (24) . Lotufo et al. showed that melatonin inhibits leukotriene B4, but not fMLP-induced rat leukocyte rolling and adhesion. They also demonstrated that the reduced transmigration of neutrophils though epithelial cells is due to melatonin action on endothelial cells and is not related to neutrophils (12, 13) .
We asked if melatonin can have a direct effect on granulocytes. To induce granulocyte infiltration into peritoneum, we used fMLP. Receptors for fMLP are present on neutrophils and macrophages (25, 26) but not on endothelial cells (27, 28) . Therefore, fMLP activates neutrophils but not endothelial cells. One of the reasons for the reduced granulocyte migration during the dark time could be a melatonin-induced decrease in the integrin-mediated cell adherence. Indeed, in vitro, using plate-bound ICAM in the absence of endothelial cells, we could show that melatonin can directly suppress integrin-mediated granulocyte adherence.
The decreased adherence could cause reduced expression of CD18 on granulocytes during the dark time, when the melatonin concentration in the plasma is higher (29) . Of note, there was no difference in the expression of Mac-1 (CD11b/ CD18) during the light or dark time (in vivo). Melatonin did not also change the fMLP-induced expression of Mac-1 in vitro (data not shown). Therefore, the decreased expression of CD18 during the dark time could be due to changes in expression of LFA-1 (CD11a/CD18).
CD18 is very important for the migration of murine neutrophils into the peritoneal cavity (30) . The mechanism behind the regulation of CD18 expression by melatonin is unclear. Lotufo et al. showed that melatonin had no effect on fMLPinduced CD18 expression in rat leukocytes in vitro (13); however, Chen et al. demonstrated that melatonin downregulated CD18 expression that was increased in neutrophils from patients with severe acute pancreatitis (in vivo) (31) . In vivo, in murine neutrophils, we found decreased expression of CD18 during the dark time as compared with the light time, and this was not due to circadian time, since mice kept at constant lighting had higher levels of CD18 independent of circadian time. Further, we have showed that melatonin suppresses fMLP-induced CD18 up-regulation in vitro acting via the MT2 melatonin receptor. It was previously demonstrated that melatonin also inhibits the expression of adhesion molecules on endothelial cells (32) . Melatonin reduces the adhesion of neutrophils to post-capillary veins in rats. Endothelial cells obtained from rats that had lower nocturnal melatonin concentrations expressed significantly higher levels of adhesion molecules and had an increased leukocyte adherence than cells from animals that had normal nocturnal levels of melatonin (33) . Endothelial cells cultured from rats killed during daytime expressed higher levels of ICAM-1 than the cells obtained from animals killed during night time (34).
Lotufo et al. showed that melatonin inhibits the leukocyte adhesion to endothelial cells via MT3/QR2 receptor expressed on endothelial cells (12, 13) . We investigated fMLP-induced granulocyte adhesion to the plate-bound ICAM that was observed after a short (3-4 min) time and the adhesion to the plate-bound ICAM of unstimulated cells that was observed after 30-40 min. We found that melatonin suppresses adhesion of both fMLP-stimulated and unstimulated granulocytes. The adhesion of unstimulated granulocytes is suppressed by melatonin via MT3/QR2 receptor. Other melatonin receptors (surface and nuclear receptors) were not involved. Melatonin regulates the adhesion of fMLP-stimulated cells via the MT2 receptor since the MT2 agonist IIK7 acts similarly to melatonin and the MT2 antagonist 4P-PDOT and also the MT1/MT2 antagonist luzindole restored melatonin-suppressed adhesion. Although MT3/QR2 agonist Gr135531 inhibited the adhesion similarly to melatonin, the MT3/QR2 antagonist prazosin hydrochloride did not show any effect. From those results, we could speculate that the signaling pathways though MT2 and MT3/QR2 melatonin receptors could be coupled. Since MT2 
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and MT1/MT2 agonists blocked the action of melatonin, but MT3/QR2 antagonist did not, we hypothesize that MT3/QR2 activation is downstream of MT2. Similarly, the connection between signaling of melatonin surface receptor MT1 and nuclear receptor RORα was described by Lardone et al. (35) . Furthermore, melatonin augmented the expression of the MT3/QR2 receptor on granulocytes. How melatonin and MT3/ QR2 melatonin receptor can be involved in the suppression of the granulocyte adhesion is unclear. Actin microfilament organization is important for cell migration and adhesion. Melatonin has been shown to co-localize with actin and thereby change actin microfilament organization (36, 37) .
Another possibility is that melatonin can participate in the regulation of the amount of free radicals. Melatonin acts as a receptor-independent free radical scavenger (38) or it can inhibit production of free radicals via binding to MT3/QR2 (39) . There are data showing that the low and high concentrations of melatonin act differently: low concentrations (pM, nM and up to 0.5 mM) increase, but high concentrations reduce phorbol 12-myristate 13-acetate-induced formation of ROS in human neutrophils (40) . Melatonin alone (above 5 − 10 −11 M) was able to induce the production of ROS in human monocytes in a protein kinase C (PKC)-dependent manner (41) . According to our unpublished data, melatonin increases fMLP-induced formation of ROS at high concentrations (10 µM); however, we did not get reproducible significant results with the low melatonin concentrations which were used for adhesion experiments. The amount of free radicals might affect neutrophil migration. For instance, the migration of neutrophils can be inhibited by drugs that inhibit superoxide release (42, 43) . Moreover, migration of neutrophils toward the chemoattractant fMLP depends on the generation of ROS by the phagocytes (44) . There are data showing that ROS and reactive nitrogen species (RNS) have an effect on Rho family GTPases that play an important role for cell migration and adhesion. Specifically, Rac could be activated and Rho can be both activated and inhibited/suppressed by free radicals (44) (45) (46) . Thus, melatonin can be indirectly involved in modulation of the activity of Rac and Rho GTPases via regulation of ROS/RNS levels.
Rac and Rho GTPases function as critical regulators of actin cytoskeleton remodeling during cell spreading and migration. The activity of Rho is responsible for the assembly of actin stress fibers and focal adhesions, whereas Rac is involved in the generation of lamellipodia and focal complexes (46) . Melatonin can also modulate the activity of Rho via the PKC pathway. There are many data showing that melatonin can activate PKC (47) (48) (49) (50) (51) or decrease its activity (52, 53) . However, some authors showed that melatonin activates PKC though MT1/MT2 receptors (54) (55) (56) . The influence of MT3/Q2 was not investigated. It was demonstrated that melatonin activates not only PKC but also Rho-associated protein kinase ROCK that is downstream of the PKC signaling pathway and is activated by the small GTPase Rho. Melatonin acting via PKC and ROCK regulate cytoskeletal dynamics: it increases stress fibres and focal adhesions and inhibits ruffle formation in MDCK, N1E-115 and cancer MCF-7 cell lines (57) (58) (59) . It changes highly migratory microfilament ruffles and lamelipodia to stress fibres that are microfilament phenotypes of attached cells. So, according to these data, melatonin should not decrease but increase the adhesion. However, other authors showed that PKC induces down-regulation of Rho-activity in vascular smooth muscle cells, whereas Rac activity remained unaffected (60). Liu et al. showed that RhoA kinase (ROCK) in human neutrophils promotes integrin-mediated de-adhesion by inhibiting cytoskeletal-dependent spreading. Activation of RhoA kinase leads to actomyosin assembly and contraction with cell rounding, thus decreasing spreading and reducing avidity (61) .
Melatonin may influence CD18 activity also via PKC, while PKC phosphorylates the cytoplasmic domain of the CD18 chain during human leukocyte activation. As a consequence, the integrins are activated (62) (63) (64) .
In summary, the action of melatonin on PKC and Rho/ROCK activation and the mechanisms of regulation the adhesion are controversial. It could depend on melatonin concentration and/or the origin of the cells.
Taken together, murine granulocyte infiltration into the peritoneum during the dark time is decreased as compared with the light time. It may be dependent on decreased CD18 expression during the dark time as well as on the reduced granulocyte adhesion to ICAM. The decreased CD18 expression and the reduced adhesion are due to melatonin action via its MT2 and MT3/QR2 receptors.
